Dr. Mark F. Conrad, MD

Dr. Conrad practices at Boston Medical Center - Brighton in Brighton, Massachusetts, part of Boston Medical Center Health System.

Dr. Conrad's NPI, 1306810007, was assigned on February 17, 2006. Dr. Conrad graduated from University of Michigan Medical School in 1997. Dr. Conrad holds Massachusetts license 220028.

Dr. Conrad's primary practice is Boston Medical Center - Brighton, at 736 Cambridge Street, Nevins Building, Brighton, MA 02135 in Suffolk County. The practice phone is (617) 789-3000.

Dr. Conrad's primary practice is Boston Medical Center - Brighton in Brighton, Massachusetts, part of Boston Medical Center Health System. Dr. Conrad is also affiliated with Massachusetts General Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Conrad to 3 more hospitals, 4 medical groups, 3 group practices and clinics and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Conrad practices, 9 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Conrad's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Conrad is licensed in Massachusetts.

CMS data shows 252 Medicare services from Dr. Conrad across 6 procedure codes in 2024, for 209 Medicare patients. Medicare paid $26,817 for them.

CMS counts 209 Medicare patients who saw Dr. Conrad in 2024. The largest group is 75 to 84, with 92 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Conrad's median patient age at 73, with 42% women.

In 2020, Dr. Conrad wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $12 in total drug cost. In 2017, CMS named 26 claims across 2 drugs.

Dr. Conrad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 15 procedures of leg revascularization (restoring blood flow) by Dr. Conrad, more than 72% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 135 papers to Dr. Conrad, published from 2008 to 2025. 2020 was the busiest year, with 17. The most frequent topics are Endovascular Procedures, Blood Vessel Prosthesis Implantation and Postoperative Complications. Dr. Conrad has published most often in J Vasc Surg. Dr. Conrad's most frequent co-authors are Laura Teresa Boitano, MD, Jahan Mohebali, MD and William D. Clouse, MD.

Dmand AI links Dr. Conrad to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Aortic Aneurysm, Abdominal, Chronic Limb-Threatening Ischemia and Constriction, Pathologic. C. R. Bard sponsors the most, 3. Open Payments lists research payments to Dr. Conrad that name 3 trials.

CMS Open Payments shows 463 general payments to Dr. Conrad from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 81% of the total. Endologix, Inc. paid the most, $122,906. It also lists 45 research payments totaling $71,350 from 2016 to 2025, naming 3 clinical trials.

Dr. Conrad graduated from University of Michigan Medical School in 1997.